• Center on Health Equity and Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

Seventy Percent of Liver Cancer Cases in the US Could be Prevented


GLI Spearheads Initiative to Double the Five-Year Survival Rate by 2030

Washington, DC — The Global Liver Institute (GLI), along with 33 other leading health and medical organizations, has issued a global call-to-action to increase the five-year survival rate for liver cancer from 18% to 36% by 2030.

Liver cancer is a leading cause of cancer deaths worldwide, accounting for more than 700,000 deaths each year. In the United States this year alone more than 42,000 people will be diagnosed with liver cancer and more than 31,000 people will die from this disease. The National Cancer Institute estimates that there were more than 83,000 people living with liver cancer in the United States in 2016.

To read the full press release click here.

Related Videos
Chase D. Hendrickson, MD, MPH
Takiyah Durham, MBA, and Margaret Larkins-Pettigrew, MD
Afreen Idris Shariff, MD, MBBS, Duke Cancer Institute
 Brian Mullen, PhD, head of innovation and product, The Clinic by Cleveland Clinic
Mike Koroscik, MBA, MHA, Allina Health and the Allina Health Cancer Institute
Ted Okon, MBA, Community Oncology Alliance
dr erin gillaspie
Miriam J. Atkins, MD, FACP, Community Oncology Alliance/AO Multispecialty Clinic
Lalan Wilfongd, MD, US Oncology Network
Related Content
© 2023 MJH Life Sciences
All rights reserved.